Scientific Program First Saudi International Conference on Pharmaceutical Policy, Economics & Outcomes KSAU-HS Convention Center Day 1, 20 October 2014 Time Topics 0700 – 0802 Registration Chair: Dr. Yousef Asiri, Dean, College of Pharmacy, KSU 0802 – 0042 Introduction of HTA & Pharmacoeconomics Evaluation 0042 – 2022 Comparative Effectiveness Research 0922 – 0902 Importance of National Pharmacoeconomics/Submission Guidelines 2022 – 2042 Pharmacoeconomics/Submissions Guidelines in Europe 2042 – 0950 Pharmacoeconomics/Submission Guidelines in Australia Speakers Prof. Mike Drummond, Past President ISPOR & Director, Center for Health Economics, University of York, UK. Prof. Sean Sullivan Dean, College of Pharmacy, University of Washington, USA Prof. Mike Drummond, Past President ISPOR & Director, Center for Health Economics, University of York, UK. Dr. Ivo Abraham Professor, College of Pharmacy & Director, Health Outcome and Pharmaconeconomics Research Center Arizona University, USA Dr. Dhafer Al-Shiban, Arizona University 0950 – 1000 Panel Discussion 1000 – 1040 OPENING CEREMONY 1040 – 1100 Coffee Break Chair: Dr. Ibrahim Al-Jaffali, Vice-President, Drug Sector, Saudi Food & Drugs Administration (SFDA) Prof. Sean Sullivan 1102 – 1132 Reference Pharmaceutical Pricing Dean, College of Pharmacy, University of Washington, USA Dr. Fahad Al-Nutaify, Director, Pricing 1102 – 1102 Pharmaceutical Pricing in Saudi Arabia and Pharmacoeconomics Directorate, Saudi Food and Drug Authority (SFDA) How Would Value Based Pricing Improve Pharmaceutical Prof. Mike Drummond, Past President 1102 – 1002 Reimbursement Decision by Health Care Institutions ISPOR, Director, Center for Health (Payers) Economics, University of York, UK. 1020 – 1030 Panel Discussion Lunch/Prayer Break Afternoon Workshops Workshop on National Pharmacoeconomics / Submission Guidelines Development 1330 –1630 Pharmacist Role in Establishing Disease Management Programs Pharmacist Role in Medication Therapy Management Services 1500 – 1530 Prayer Time/Coffee Break End Of Day 1 Prof. Mike Drummond, Past President ISPOR & Director, Center for Health Economics, University of York, UK Dr. Abdulaziz Al-Saggabi, Director, Drug Policy & Economics Center, Ministry of National Guard Health Affairs Dr.Dough Burgoyne, President, Academy of Managed Care Pharmacy & President VRX Pharmacy Services, LLC, USA Dr.Pete Penna, CEO,Formulary Resources CoFounder & Past President of Academy of Managed Care Pharmacy, USA Scientific Program First Saudi International Conference on Pharmaceutical Policy, Economics & Outcomes KSAU-HS Convention Center Day 2, 21 October 2014 Time Topics Speakers Chair: Dr. Majed Al-Jeraisy, Chairman Co-Chair: Dr. Ahmad Al Miman, Dean Research Office, KAIMRC College of Pharmacy, Qaseem University Dr. Ivo Abraham Types of Local Outcomes Research Required to Professor, College of Pharmacy & Director, 0800 – 0830 Support Pharmacoeconomics/HTA Studies in Saudi Health Outcome and Pharmaconeconomics Arabia Research Center Arizona University Need for Real World Data from National Databases & Prof. Sean Sullivan 0830 – 0900 Registries to Support HTA & Pharmacoeconomics Dean, College of Pharmacy, University of Evaluation Washington, USA Outcomes Research in Saudi Arabia: Role in HTA/ Dr. Mohammad Al-Kelya, Head, Research 0900 – 0920 Pharmacoeconomics Evaluation Quality Management, KAIMRC Role of Pharmacoepidemiology in Dr. Thamer Al-Shammari, Dean, College of 0920 – 0940 Pharmacoeconomics Evaluation Pharmacy, University of Hail Impact of Pharmacoeconomics & Outcomes Research Prof. L Bootman, Dean, College of 0940 – 1010 on Quality of Patient Care Pharmacy, Arizona University 1010 – 10:20 1020 – 1030 Panel Discussion Coffee Break Chair: Dr. Yousef Al-Omi, General Director Co-Chair: Dr. Hani Al Hamdan, Director Pharmaceutical Care, MOH Pharmaceutical Care Services, KAMC-Western Region Performance (Outcomes) Based Risk Sharing Prof. Sean Sullivan 1030 – 1100 Agreement (PBRSAs) Between Pharmaceutical Dean, College of Pharmacy, University of Industry & Health Care Institutions (Payers) Washington, USA Dr. Abdulaziz Al-Saggabi, Director, Drug 1100 – 1120 Optimal implementation of Outcomes Based Risk Policy & Economics Center, Ministry of Sharing Agreements in Saudi Arabia National Guard Health Affairs 1120 – 1130 1130 – 1140 Panel Discussion Coffee Break Chair: Dr. Abdulmalik Al-Katheri, Dean, College of Pharmacy, KSAU-HS Arizona University Experience in Building Capacity in 1140 – 1200 Pharmaceutical Policy, Economics & Outcomes University of Washington Experience in Building 1200 – 1220 Capacity in Pharmaceutical Policy & Outcomes Research 1220 – 1230 1230 –1330 Conducting Optimal HTA 1330 – 1630 Panel Discussion Lunch / Prayer Break Afternoon Workshops Prof. Mike Drummond, Past President ISPOR & Director, Center for Health Economics, University of York, UK. Dr. Abdulaziz Al-Saggabi, Director, Drug Policy & Economics Center, MNGHA Performance-Based (Outcomes Based) Risk Sharing Agreements Between Pharmaceutical Industry and Health Care Institutions (Payers) 1500 – 1530 Prof. L Bootman, Dean, College of Pharmacy, Arizona University Prof. Sean Sullivan Dean, College of Pharmacy, University of Washington, USA Prof. Sean Sullivan Dean, College of Pharmacy, University of Washington , USA Prayer Time/Coffee Break End Of Day 2 Scientific Program First Saudi International Conference on Pharmaceutical Policy, Economics & Outcomes Time KSAU-HS Convention Center Day 3, 22 October 2014 Topics Speakers Chair: Dr. Hamdan Al-Jahdali, Chairman, Corporate P&T Committee, KAMC, MNGHA Deputy Chairman, Dept. of Medicine, KAMC-Riyadh 0830 – 0850 Pharmacoeconomics Evaluation: MNGHA Experiences 0850 – 0910 Formularly Management 0910 – 0930 Evidence-Based Health Practice Principles: Role in Drug Evaluation Dr. Ali Al-Hammad Pharmacoeconomics Specialist Drug Policy & Economics Center, MNGHA Dr. Nada Abu-Shraie Clinical Pharmacy Specialist Drug Policy & Economics Center, MNGHA Dr. Mazen Ferwana Co-Director, National & Gulf Evidence Based Health Practice Center, KSAU-HS, MNGHA Panel Discussion 0930 – 0940 0940 – 0950 Coffee Break Chair: Dr. Abdulaziz Al-Saggabi, Chairman, Scientific Committee Co-Chair: Dr. Saleh Al-Dekhail, Director Director, Drug Policy & Economics Center, MNGHA Pharmaceutical Care Services, KAMC-Central Region 0950 – 1010 US Managed Care System 1010 – 1030 Introduction of Pharmacy Benefit Management 1030 – 1050 Management Programs Services Provided by Pharmacy Benefit Management 1050 – 1110 Medication Therapy Management Services Provided by Pharmacy Benefit Management 1110 – 1140 Drug Utilization Evaluation Services by Pharmacy Benefit Management 1140 – 1200 Role of IT in Pharmacy Benefit Management Dr. Doug Burgoyne President, Academy of Managed Care Pharmacy, USA Dr. Pete Penna CEO, Formulary Resources Co-Founder & Past President of Academy of Managed Care Pharmacy, USA Dr. Doug Burgoyne President, Academy of Managed Care Pharmacy, USA Dr. Pete Penna, CEO, Formulary Resources, Co-founder & Past President of Academy of Managed Care Pharmacy, USA Dr. Jeff Dunn, Vice President, VRX Pharmacy Services, LLC USA Mr. Mark Singleton, Chief Operating Officer, Veridicus Health, LLC, USA 1200 – 1210 Panel Discussion 1210 – 1240 CLOSING CEREMONY 1240 – 1340 Lunch/ Prayer Break Afternoon Workshops Drug Utilization Review by PBM to Improve Quality of Care Dr. Jeff Dunn, Vice President, VRX Pharmacy and Manage Escalating Pharmaceutical Expenditures Services, LLC USA Mr. Mark Singleton, Chief Operating Officer, Role of IT in Pharmacy Benefit Management Veridicus Health, LLC, USA Dr. Ivo Abraham Types of Local Outcomes Research Required to Support Professor, College of Pharmacy & Director, Pharmacoeconomics/HTA Studies in Saudi Arabia Health Outcome and Pharmaconeconomics Research Center, Arizona University End Of Day 3 1340 – 1640
© Copyright 2024 ExpyDoc
